Effects of Lee Silverman Voice Treatment BIG on Dynamic Balance in Parkinson's Patients

Sponsor
Riphah International University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05490784
Collaborator
(none)
26
1
2
7.6
3.4

Study Details

Study Description

Brief Summary

To determine the effects of Lee Silverman Voice Treatment BIG on dynamic balance in Parkinson's patients

Condition or Disease Intervention/Treatment Phase
  • Other: Lee Silverman Voice Treatment BIG
  • Other: conventional treatment
N/A

Detailed Description

This study will be conducted to compare the effects of Lee Silverman Voice Treatment BIG and conventional physiotherapy on dynamic balance in patients of PD. Patients will be recruited according to inclusion criteria and data will be collected from Riphah rehabilitation center, National Hospital Lahore. Dynamic gait index will be used as data collection tool to test dynamic balance of patients. Patients will be allocated to intervention groups by randomization. After approval from ethical committee, data collection will be started and informed consent will be taken from all patients.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
26 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
total 26 participants will be randomly assigned to experimental group (Lee Silverman Voice Treatment BIG along with conventional therapy) and control group( conventional treatment)total 26 participants will be randomly assigned to experimental group (Lee Silverman Voice Treatment BIG along with conventional therapy) and control group( conventional treatment)
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Lee Silverman Voice Treatment BIG on Dynamic Balance in Parkinson's Patients
Actual Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Aug 20, 2022
Anticipated Study Completion Date :
Aug 20, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Lee Silverman Voice Treatment big with conventional treatment

Lee Silverman Voice Treatment big with conventional treatment

Other: Lee Silverman Voice Treatment BIG
Patients assigned to experimental group will get Lee Silverman Voice Treatment BIG along with conventional treatment.

Active Comparator: control group

Patients assigned to control group received conventional treatment program encompassing set of exercises such as complex motor sequences, stretching, dual tasking, mental imagery and core stability.

Other: conventional treatment
patients in this group will get conventional treatment program encompassing set of exercises such as complex motor sequences, stretching, dual tasking, mental imagery and core stability.

Outcome Measures

Primary Outcome Measures

  1. Dynamic Gait Index [9 months]

    Dynamic gait index assesses postural stability, gait, and balance. It evaluates various gait- related tasks with challenging situations such as head turn, speed change, obstacles and stairs climbing.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Stage I, II, III Parkinson's patients on Hoehn &;Yahr classification

  • Able to walk without assistive devices

  • Stable medication 4 weeks prior to and during study

Exclusion Criteria:
  • Patients with depression or dementia

  • Disabling bradykinesia to make sure patients are efficient to engage and cooperate in conventional physical therapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Riphah International University Islamabad Fedral Pakistan 44000

Sponsors and Collaborators

  • Riphah International University

Investigators

  • Principal Investigator: zeest hashmi, MSNMPT, Riphah International University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Riphah International University
ClinicalTrials.gov Identifier:
NCT05490784
Other Study ID Numbers:
  • REC/RCR & AHS/21/0253
First Posted:
Aug 8, 2022
Last Update Posted:
Aug 8, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Riphah International University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 8, 2022